Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S11 from Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma
  1. Home
  2. Publications
  3. Supplementary Figure S11 from Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma

Supplementary Figure S11 from Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma

Authors:
  • SMSmita Matkar
    Smita Matkar
  • MEMichael P. East
    Michael P. East
  • TSTimothy J. Stuhlmiller
    Timothy J. Stuhlmiller
  • GWGabriela M. Witek
    Gabriela M. Witek
  • AFAlvin Farrel
    Alvin Farrel
  • SPSteven Pastor
    Steven Pastor
  • DODenis O. Okumu
    Denis O. Okumu
  • AKAnne Kennedy
    Anne Kennedy
  • JKJoshua R. Kalna
    Joshua R. Kalna
  • EBEsther R. Berko
    Esther R. Berko
  • CCColleen E. Casey
    Colleen E. Casey
  • KKKateryna Krytska
    Kateryna Krytska

Open Access
Publisher website
Google Scholar
  • 2 September 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.30028825
Abstract
Supplementary Figure S11 shows Lorlatinib downregulates AURKA expression.
Keywords
  • DRUG RESISTANCE
  • CLINICAL DRUG RESISTANCE
  • PEDIATRIC CANCERS
  • PRECLINICAL MODELS
  • XENOGRAFT MODELS
  • SMALL MOLECULE AGENTS
  • KINASE INHIBITORS
  • TRANSLATIONAL RESEARCH
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.